About Us Services Careers FAQ Contact Us 0
Home Healthcare IT Psoriatic Arthritis Treatment Market Size, Global Trends, Top Share, Forecast to 2031
Psoriatic Arthritis Treatment Market

Psoriatic Arthritis Treatment Market Size, Share & Trends Analysis Report By Drug Type (NSAIDs, DMARDs, Biologics, Others), By Type (Prescription, OTC), By Route of Administration (Injectable, Oral, Topical) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031

Report Code: SRHI55449DR
Last Updated : Nov 28, 2024
Author : Debashree Bora
Starting From
USD 2300
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Psoriatic Arthritis Treatment Market Introduction
    2. By Drug Type
      1. Introduction
        1. Drug Type By Value
      2. NSAIDs
        1. By Value
      3. DMARDs
        1. By Value
      4. Biologics
        1. By Value
      5. Others
        1. By Value
    3. By Type
      1. Introduction
        1. Type By Value
      2. Prescription
        1. By Value
      3. OTC
        1. By Value
    4. By Route of Administration
      1. Introduction
        1. Route of Administration By Value
      2. Injectable
        1. By Value
      3. Oral
        1. By Value
      4. Topical
        1. By Value
    1. Introduction
    2. By Drug Type
      1. Introduction
        1. Drug Type By Value
      2. NSAIDs
        1. By Value
      3. DMARDs
        1. By Value
      4. Biologics
        1. By Value
      5. Others
        1. By Value
    3. By Type
      1. Introduction
        1. Type By Value
      2. Prescription
        1. By Value
      3. OTC
        1. By Value
    4. By Route of Administration
      1. Introduction
        1. Route of Administration By Value
      2. Injectable
        1. By Value
      3. Oral
        1. By Value
      4. Topical
        1. By Value
    5. U.S.
      1. By Drug Type
        1. Introduction
          1. Drug Type By Value
        2. NSAIDs
          1. By Value
        3. DMARDs
          1. By Value
        4. Biologics
          1. By Value
        5. Others
          1. By Value
      2. By Type
        1. Introduction
          1. Type By Value
        2. Prescription
          1. By Value
        3. OTC
          1. By Value
      3. By Route of Administration
        1. Introduction
          1. Route of Administration By Value
        2. Injectable
          1. By Value
        3. Oral
          1. By Value
        4. Topical
          1. By Value
    6. Canada
    1. Introduction
    2. By Drug Type
      1. Introduction
        1. Drug Type By Value
      2. NSAIDs
        1. By Value
      3. DMARDs
        1. By Value
      4. Biologics
        1. By Value
      5. Others
        1. By Value
    3. By Type
      1. Introduction
        1. Type By Value
      2. Prescription
        1. By Value
      3. OTC
        1. By Value
    4. By Route of Administration
      1. Introduction
        1. Route of Administration By Value
      2. Injectable
        1. By Value
      3. Oral
        1. By Value
      4. Topical
        1. By Value
    5. U.K.
      1. By Drug Type
        1. Introduction
          1. Drug Type By Value
        2. NSAIDs
          1. By Value
        3. DMARDs
          1. By Value
        4. Biologics
          1. By Value
        5. Others
          1. By Value
      2. By Type
        1. Introduction
          1. Type By Value
        2. Prescription
          1. By Value
        3. OTC
          1. By Value
      3. By Route of Administration
        1. Introduction
          1. Route of Administration By Value
        2. Injectable
          1. By Value
        3. Oral
          1. By Value
        4. Topical
          1. By Value
    6. Germany
    7. France
    8. Spain
    9. Italy
    10. Russia
    11. Nordic
    12. Benelux
    13. Rest of Europe
    1. Introduction
    2. By Drug Type
      1. Introduction
        1. Drug Type By Value
      2. NSAIDs
        1. By Value
      3. DMARDs
        1. By Value
      4. Biologics
        1. By Value
      5. Others
        1. By Value
    3. By Type
      1. Introduction
        1. Type By Value
      2. Prescription
        1. By Value
      3. OTC
        1. By Value
    4. By Route of Administration
      1. Introduction
        1. Route of Administration By Value
      2. Injectable
        1. By Value
      3. Oral
        1. By Value
      4. Topical
        1. By Value
    5. China
      1. By Drug Type
        1. Introduction
          1. Drug Type By Value
        2. NSAIDs
          1. By Value
        3. DMARDs
          1. By Value
        4. Biologics
          1. By Value
        5. Others
          1. By Value
      2. By Type
        1. Introduction
          1. Type By Value
        2. Prescription
          1. By Value
        3. OTC
          1. By Value
      3. By Route of Administration
        1. Introduction
          1. Route of Administration By Value
        2. Injectable
          1. By Value
        3. Oral
          1. By Value
        4. Topical
          1. By Value
    6. Korea
    7. Japan
    8. India
    9. Australia
    10. Singapore
    11. Taiwan
    12. South East Asia
    13. Rest of Asia-Pacific
    1. Introduction
    2. By Drug Type
      1. Introduction
        1. Drug Type By Value
      2. NSAIDs
        1. By Value
      3. DMARDs
        1. By Value
      4. Biologics
        1. By Value
      5. Others
        1. By Value
    3. By Type
      1. Introduction
        1. Type By Value
      2. Prescription
        1. By Value
      3. OTC
        1. By Value
    4. By Route of Administration
      1. Introduction
        1. Route of Administration By Value
      2. Injectable
        1. By Value
      3. Oral
        1. By Value
      4. Topical
        1. By Value
    5. UAE
      1. By Drug Type
        1. Introduction
          1. Drug Type By Value
        2. NSAIDs
          1. By Value
        3. DMARDs
          1. By Value
        4. Biologics
          1. By Value
        5. Others
          1. By Value
      2. By Type
        1. Introduction
          1. Type By Value
        2. Prescription
          1. By Value
        3. OTC
          1. By Value
      3. By Route of Administration
        1. Introduction
          1. Route of Administration By Value
        2. Injectable
          1. By Value
        3. Oral
          1. By Value
        4. Topical
          1. By Value
    6. Turkey
    7. Saudi Arabia
    8. South Africa
    9. Egypt
    10. Nigeria
    11. Rest of MEA
    1. Introduction
    2. By Drug Type
      1. Introduction
        1. Drug Type By Value
      2. NSAIDs
        1. By Value
      3. DMARDs
        1. By Value
      4. Biologics
        1. By Value
      5. Others
        1. By Value
    3. By Type
      1. Introduction
        1. Type By Value
      2. Prescription
        1. By Value
      3. OTC
        1. By Value
    4. By Route of Administration
      1. Introduction
        1. Route of Administration By Value
      2. Injectable
        1. By Value
      3. Oral
        1. By Value
      4. Topical
        1. By Value
    5. Brazil
      1. By Drug Type
        1. Introduction
          1. Drug Type By Value
        2. NSAIDs
          1. By Value
        3. DMARDs
          1. By Value
        4. Biologics
          1. By Value
        5. Others
          1. By Value
      2. By Type
        1. Introduction
          1. Type By Value
        2. Prescription
          1. By Value
        3. OTC
          1. By Value
      3. By Route of Administration
        1. Introduction
          1. Route of Administration By Value
        2. Injectable
          1. By Value
        3. Oral
          1. By Value
        4. Topical
          1. By Value
    6. Mexico
    7. Argentina
    8. Chile
    9. Colombia
    10. Rest of LATAM
    1. Psoriatic Arthritis Treatment Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. AbbVie Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Amgen Inc.
    3. Bristol-Myers Squibb Company
    4. Celgene Corporation
    5. Eli Lilly and Company
    6. Johnson & Johnson Services, Inc.
    7. Novartis International AG
    8. Pfizer, Inc.
    9. UCB S.A.
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Osteoarthritis Treatment Market Size The global osteoarthritis treatment market size was valued at USD 6.20 billion in 2021 and is projected to reach USD 10.35 billion by 2030, growing at a CAGR of 5.86% during the fore
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright . All rights Reserved.